This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Sign in
Sign in
Sign out

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Explore Content

Learn about ATTR-CM and uncover the differences between hereditary and wild-type ATTR-CM

Learn about the red flags that may raise suspicion of and techniques used to diagnose ATTR-CM

Explore a range of educational resources to support the diagnosis of ATTR-CM

Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Expert videos

Dr Nigel Lewis (Sheffield Teaching Hospitals, Sheffield)

Red Flags of ATTR-CM

Summary of Nigel Lewis' presentation at the BCS Symposium 2021 highlighting the red flags for ATTR-CM including the cardiac and non-cardiac manifestations.

Contact us

** This is an optional area where footnotes can live.

Dr Kate Gatenby (Leeds General Infirmary, Leeds)

Diagnosis of ATTR-CM

Summary of Kate Gatenby's presentation at the BCS Symposium 2021 highlighting the characteristic findings on imaging that would point to a diagnosis of ATTR-CM.

Contact us

** This is an optional area where footnotes can live.

Dr Will Moody (Queen Elizabeth Hospital, Birmingham)

Management of ATTR-CM

Summary of Will Moody's presentation at the BCS Symposium 2021, discussing a case study of a patient diagnosed with ATTR-CM.

Contact us

** This is an optional area where footnotes can live.

Building the knowledge: Biological foundations of ATTR amyloidosis

This module reviews the biological foundation and disease mechanism of ATTR amyloidosis.

Building the knowledge: Navigating the ATTR amyloidosis landscape

This video reviews the disease landscape, and highlights differences between wtATTR amyloidosis and hATTR amyloidosis.

Building the knowledge: One disease with many faces

​​​​​​​This video breaks down the various types of ATTR amyloidosis and the clinical clues that can raise suspicion of ATTR-CM.

Building the knowledge: ​​​​​​​The patient journey to diagnosis of ATTR-CM, a race against time

This module reviews the importance of an early diagnosis of ATTR-CM.

Building the knowledge: Appropriately diagnosing ATTR-CM

The last in the series video reviews non-invasive and invasive approaches for the diagnosis of ATTR-CM.

Dr Robert Cooper (Liverpool Heart and Chest Hospital, Liverpool)

Imaging techniques for diagnosis of cardiac amyloidosis

'Ask the expert' video from the 2020 BSH Congress Symposium with Rob Cooper. Rob highlights the symptoms of cardiac amyloidosis and provides an in-depth explanation of the imaging techniques used in combination to diagnose cardiac amyloidosis accurately.

Dr Lisa Anderson (St George's Hospital, London) ​​​​​​​

Tips for Detecting Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Summary video from the 2020 BSH Congress Symposium with Lisa Anderson, who shares some important tips for helping you to detect TTR cardiac amyloidosis, including example criteria of a patients history.

Explore more

See other educational resources available

Explore more

PP-VYN-GBR-0968. March 2022

Quick Links

Register to receive tailored marketing information from Pfizer by email

Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.

PP-PFE-GBR-2809. October 2020

Sign up now

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

Yes

No

OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?